644 related articles for article (PubMed ID: 17100105)
1. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM
Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105
[TBL] [Abstract][Full Text] [Related]
2. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
3. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.
Roukens AH; Vossen AC; van Dissel JT; Visser LG
Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158
[TBL] [Abstract][Full Text] [Related]
4. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
[TBL] [Abstract][Full Text] [Related]
5. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
[TBL] [Abstract][Full Text] [Related]
6. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A
Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510
[TBL] [Abstract][Full Text] [Related]
7. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies.
Madhusudana SN; Anand NP; Shamsundar R
Natl Med J India; 2001; 14(3):145-7. PubMed ID: 11467142
[TBL] [Abstract][Full Text] [Related]
9. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
[TBL] [Abstract][Full Text] [Related]
10. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection.
Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V
Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972
[TBL] [Abstract][Full Text] [Related]
11. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V
Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097
[TBL] [Abstract][Full Text] [Related]
12. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
[TBL] [Abstract][Full Text] [Related]
13. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
[TBL] [Abstract][Full Text] [Related]
14. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.
Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C
Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080
[TBL] [Abstract][Full Text] [Related]
15. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
[No Abstract] [Full Text] [Related]
16. Response to purified chick embryo cell rabies vaccine administered intradermally for post-exposure prophylaxis.
Madhusudana SN; Anand NP
Natl Med J India; 1997; 10(3):115-6. PubMed ID: 9230599
[TBL] [Abstract][Full Text] [Related]
17. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
Vien NC; Feroldi E; Lang J
Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):294-6. PubMed ID: 18191971
[TBL] [Abstract][Full Text] [Related]
18. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment.
Ubol S; Phanuphak P
Clin Exp Immunol; 1986 Mar; 63(3):491-7. PubMed ID: 3708902
[TBL] [Abstract][Full Text] [Related]
19. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine.
Sampath G; Madhusudana SN; Sudarshan MK; Ashwathnarayana DH; Mahendra BJ; Ullas TP; Mohan K; Madhusudhan SK; Ravish HS
Vaccine; 2010 May; 28(24):4086-90. PubMed ID: 20403351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
